Auration Biotech, Inc is a biotechnology company based in Chapel Hill, NC, with a vision to develop innovative therapeutics for the treatment of ear, nose, and throat diseases. Founded in 2014 by Benjamin F. McGraw, III, Sanjay Chanda, and Peter Santa Maria, the company focuses on the development of novel products such as AU-935 HB-EGF for non-surgical repair of tympanic membranes and AU-934 KB-R7785 as an alternative to tympanotomy tubes.
With undisclosed research stage products, Auration Biotech, Inc aims to revolutionize the field of otolaryngology by providing effective solutions for various ear, nose, and throat conditions. Through their dedication to scientific advancement and collaboration, the company strives to make a significant impact on the healthcare industry.
Generated from the website